Refine
Has Fulltext
- yes (226)
Is part of the Bibliography
- yes (226)
Year of publication
Document Type
- Journal article (118)
- Doctoral Thesis (107)
- Other (1)
Keywords
- Neisseria meningitidis (43)
- Echinococcus (14)
- Fuchsbandwurm (13)
- Meningokokken (8)
- MRSA (7)
- Candida (6)
- Haemophilus influenzae (6)
- Tanzania (6)
- meningococcal disease (6)
- Candida albicans (5)
- Meningitis (5)
- Staphylococcus aureus (5)
- Virulenz (5)
- neisseria meningitidis (5)
- Aspergillus (4)
- Biofilm (4)
- Candida auris (4)
- Echinococcus multilocularis (4)
- Genexpression (4)
- Germany (4)
- Helicobacter pylori (4)
- Signaltransduktion (4)
- Virulenzfaktor (4)
- antimicrobial resistance (4)
- infection (4)
- meningitis (4)
- meningococci (4)
- stem cells (4)
- virulence (4)
- Alveoläre Echinokokkose (3)
- Bandwürmer (3)
- COVID-19 (3)
- Dimorphismus (3)
- Fusarium (3)
- Genregulation (3)
- HBMEC (3)
- Insulin (3)
- Komplement <Immunologie> (3)
- MAP-Kinase (3)
- Meningococci (3)
- Neisseria (3)
- Neisseria gonorrhoeae (3)
- Parodontitis (3)
- Phylogenie (3)
- RIM101 (3)
- SARS-CoV-2 (3)
- Serotonin (3)
- Sphingolipide (3)
- Toxoplasma gondii (3)
- alveolar echinococcosis (3)
- cestode (3)
- gene expression (3)
- inflammation (3)
- multilocularis (3)
- pH (3)
- sphingolipids (3)
- tapeworm (3)
- ARONJ (2)
- Anidulafungin (2)
- Antibiotikaresistenzen (2)
- Antibiotikum (2)
- Antimykotikaresistenz (2)
- Apoptosis (2)
- Aspergillus fumigatus (2)
- BDG (2)
- BMP (2)
- Bakterielle Infektion (2)
- Bakterien (2)
- Blut-Hirn-Schranke (2)
- Brain endothelial cells (2)
- C5aR1 (2)
- Ceramide (2)
- Cyclo-AMP (2)
- Dendritische Zelle (2)
- Echinococcosis (2)
- Epidemiologie (2)
- Epithel (2)
- Escherichia coli K1 (2)
- FarR (2)
- Genanalyse (2)
- Group B Streptococcus (2)
- Helicobacter (2)
- Hitzeschock (2)
- Infektion (2)
- Legionella pneumophila (2)
- MITE (2)
- MLST (2)
- Medizin (2)
- Microarray (2)
- Mikrobiologie (2)
- NAD (2)
- Neisseria lactamica (2)
- O-Acetylierung (2)
- Parasit (2)
- Pathogenität (2)
- Proteomanalyse (2)
- Rhizopus (2)
- Sequenzanalyse (2)
- Serumresistenz (2)
- Smad (2)
- Stammzelle (2)
- Stem cell (2)
- Tapeworm (2)
- Torulopsis glabrata (2)
- Trans-Spleißen (2)
- Transkription <Genetik> (2)
- Transkriptomanalyse (2)
- Typisierung (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- Zellzyklus (2)
- antifungal susceptibility (2)
- antigen (2)
- antimicrobial stewardship (2)
- bacteria (2)
- bacterial meningitis (2)
- bacterial pathogens (2)
- benzimidazole (2)
- beta-D-glucan (2)
- biofilm (2)
- blood-brain barrier (2)
- blood–brain barrier (2)
- brain endothelial cells (2)
- candidemia (2)
- cell wall (2)
- chemotherapy (2)
- colonization (2)
- comparative genomics (2)
- diagnosis (2)
- dimorphism (2)
- echinococcus multilocularis (2)
- epidemiology (2)
- epithelial cells (2)
- flagella (2)
- flatworm (2)
- foxtapeworm (2)
- galactomannan (2)
- gene conversion (2)
- genome sequencing (2)
- granulocytes (2)
- haemophilus influenzae (2)
- homologous recombination (2)
- host-pathogen interaction (2)
- human brain microvascular endothelial cells (2)
- in vitro (2)
- in vivo (2)
- infection control (2)
- men who have sex with men (2)
- meningococcus (2)
- microbiology (2)
- neuroinflammation (2)
- neutrophils (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- outer membrane protein (2)
- oxidative stress (2)
- pathogens (2)
- periodontitis (2)
- phase variation (2)
- platyhelminthes (2)
- regulation (2)
- sepsis (2)
- serum resistance (2)
- signaltransduction (2)
- surgical site infection (2)
- trans-splicing (2)
- transcriptome (2)
- typing (2)
- 1 (1)
- 16S (1)
- 16S rRNA (1)
- 16S rRNA Sequenzanalyse (1)
- 16S rRNA analyses (1)
- 16S-rDNA (1)
- 3-ß-D-Glucan Synthase (1)
- 3-ß-D-Glucan Synthetase (1)
- 5-methyl cytosine (1)
- ACAT (1)
- ADP-Ribosyltransferasen (1)
- Abl (1)
- Acetylated tubulin (1)
- Acetylierung (1)
- Adhärenz und Invasion (1)
- Adhäsine (1)
- Adärenz (1)
- Alkaline phosphatase (1)
- Alternaria (1)
- Alveolar echinococcosis (1)
- Amphotericin B (1)
- Anaphylatoxine (1)
- Anaphylatoxinrezeptoren (1)
- Antimikrobieller Wirkstoff (1)
- Antimykotika (1)
- Antimykotikum (1)
- Aquaporin (1)
- Argonaute (1)
- Ascaris lumbricoides (1)
- AurisID (1)
- Außenmembranprotein Opc (1)
- B neisseria meningitidis (1)
- BLAST (1)
- BMP Signaling (1)
- BacT/ALERT (1)
- Bacterial Fitness (1)
- Bacterial meningitis (1)
- Bakterielle Hirnhautentzündung (1)
- Bakterielle Infek (1)
- Bakterienkapsel (1)
- Bakterienlast (1)
- Bandwurm (1)
- Behandlung (1)
- Benzimidazolderivate (1)
- Benzimidazoles (1)
- Besiedelung (1)
- Bettnetz (1)
- Bilharziose (1)
- Biohazard (1)
- Biosynthese (1)
- Blood-Brain Barrier (1)
- Blut-Liquor-Schranke (1)
- Bootstrap-Statistik (1)
- Brugia Malayi (1)
- C-reactive protein (1)
- C. glabrata (1)
- C.albicans (1)
- C.dubliniensis (1)
- C3a (1)
- C3aR (1)
- C4bp (1)
- C5a (1)
- C5aR2 (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- CNS-Infection (1)
- CO2 (1)
- COVID-19 testing (1)
- COVID‐19 (1)
- CPG binding domain (1)
- Cabin surfaces contaminated with MRSA (1)
- Calibration (1)
- Campylobacter jejuni (1)
- Cancer treatment (1)
- Candida glabrata (1)
- Candida lusitaniae (1)
- Carboanhydrase (1)
- Caspase (1)
- CdPHR (1)
- Cefotaxim (1)
- Ceramid-reiche Membrandomänen (1)
- Ceramide-enriched membrane domains (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Cestoden (1)
- Chagas disease (1)
- Chemotaxis (1)
- Chemotherapie (1)
- Chemotherapy (1)
- Chitobiose (1)
- Cholerae (1)
- Cholesterin (1)
- Circinella (1)
- Clinical prediction rule (1)
- Colombia (1)
- Colonization (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- Competitive Growth (1)
- Core-Oligosaccharid (1)
- Cryptococcus neoformans (1)
- Cytokine (1)
- DNA (1)
- DNA methylation (1)
- DNA microarrays (1)
- DNA recombination (1)
- DNA-Microarrays (1)
- Dendritic cell (1)
- Dendritische Zellen (1)
- Densovirus (1)
- Desinfektion (1)
- Disaster response (1)
- Doxycycline (1)
- Doxyzyklin (1)
- Durchblutungsmessung (1)
- DyP-Typ Peroxidase (1)
- DyP-type peroxidase (1)
- E-Test (1)
- E. multilocularis (1)
- EGF (1)
- EGF-Rezeptor (1)
- EGF-receptor (1)
- EHEC (1)
- ERG Gene (1)
- ERM- Faktor (1)
- ERM- factor (1)
- ESBL (1)
- ET-15 clone (1)
- ET-15-Meningokokken (1)
- ET-15-meningococci (1)
- ET-37 Komplex (1)
- ET-37 complex (1)
- Echinokokkus (1)
- Ecinococcus multilocularis (1)
- Efflux transport (1)
- Eingeweidewürmer (1)
- Elderly (1)
- EmERK (1)
- Emergence (1)
- Endosymbiont (1)
- Endothel (1)
- Endothelpermeabilität (1)
- Enterobacteriaceae (1)
- Entwicklung (1)
- Entwicklungsbiologie (1)
- Enzym (1)
- Epigenetic (1)
- Epithel und Endothelzellen (1)
- Epithelzellen (1)
- Ergosterolsyntheseweg (1)
- Escherichia coli (1)
- Escherichia coli infections (1)
- Eucestoda (1)
- Europe (1)
- Evolution (1)
- Expansion microscopy (1)
- Extrazelluläre Matrix (1)
- FKS (1)
- FKS Gene (1)
- FKS-genes (1)
- Faktor H (1)
- False positive reactions (1)
- Fibronektin (1)
- Fibronektin-Bindeprotein (1)
- Filamentierung (1)
- Filariose (1)
- FinO family (1)
- Fitness (1)
- Fks1 (1)
- Flagellen (1)
- Flagellin (1)
- Flagelline (1)
- Fox tapeworm (1)
- FoxQ2 (1)
- Fungiplex Candida Auris (1)
- GM (1)
- Geamtgenomsequenz (1)
- Gehirnendothelzellen (1)
- Geißel <Biologie> (1)
- Gene silencing (1)
- Genom (1)
- Genom-Vergleich (1)
- Genominsel (1)
- Geriatric care (1)
- Geriatrics (1)
- Germinative Zellen (1)
- Germinative cell (1)
- Glutathione (1)
- Golgi (1)
- Gompertz-Funktion (1)
- Guillain-Barr'e-Syndrom (1)
- Guillain-Barré Syndrom (1)
- Guillain-Barré syndrome (1)
- HFQ (1)
- HIV (1)
- Haemophilus (1)
- Haemophilus haemolyticus (1)
- Heat shock (1)
- Hefeartige Pilze (1)
- Heilmittel (1)
- Helicobacter hepaticus (1)
- Helminth (1)
- Helminths (1)
- Herzmuskel (1)
- Hfq (1)
- High throughput screening (1)
- Hirnendothelzellen (1)
- Homeobox-Gene (1)
- Homoplasie Testung (1)
- Homoplasy Ratio (1)
- Hornhautinfektionen (1)
- Hospital emergency plan (1)
- Hospitalismus <Hygiene> (1)
- Host-parasite interaction (1)
- Host-pathogen interactions (1)
- Hox-Gene (1)
- HrpB (1)
- Hyperletale Feintypen (1)
- Hyphe (1)
- Hypophosphatasia (1)
- Hypophosphatasie (1)
- I-lactate (1)
- IA (1)
- ICM (1)
- IDSA (1)
- IMD (1)
- IctP (1)
- Imatinib (1)
- Imipenem (1)
- Immunmodulation (1)
- Immunologie (1)
- Immunomodulation (1)
- Immunoparasitologie (1)
- Immunreaktion (1)
- Immunsuppression (1)
- Impfstoff (1)
- Impfstoffentwicklung (1)
- In-vitro-Kultur (1)
- Inasive Meningokokkenerkrankung (1)
- Inducible Clindamycin Resistance (1)
- Induzierte pluripotente Stammzelle (1)
- Infection control (1)
- Inhibitor (1)
- Innate immunity (1)
- Invasive Fungal Infections (1)
- Invasive Mykosen (1)
- Invasivität (1)
- Jurkat cells (1)
- Kapazität (1)
- Kapsel (1)
- Kapsel <Mikrobiologie> (1)
- Kapsel O-Acetylieung (1)
- Katalase (1)
- Kinase inhibitor (1)
- Kind (1)
- Kinderheilkunde (1)
- Klonalität (1)
- Klonbanken (1)
- Knochen-Morphogenese-Proteine (1)
- Knockout <Molekulargenetik> (1)
- Kohlendioxid (1)
- Kohlendioxidfixierung (1)
- Komplement (1)
- Komplement C3a (1)
- Komplement C5a (1)
- Konfokale Mikroskopie (1)
- Krankentransportwagen (1)
- Krankheitsübertragung (1)
- Kurzzeittransporten (1)
- Körperachsen (1)
- LOS sialylation (1)
- LPS-Sialylierung (1)
- LTR retrotransposons (1)
- Larvae (1)
- Leptomeningeal cells (1)
- Leptomeningealzellen (1)
- Letalität (1)
- Lichtheimia (1)
- Lipopolysaccharid (1)
- Lipopolysaccharid-Biosynthese (1)
- Lipopolysaccharide (1)
- Listeria monocytogenes (1)
- MALDI-MS (1)
- MALDI-TOF-MS (1)
- MAP kinase (1)
- MDR (1)
- MRONJ (1)
- MRSA-Kontamination von Oberflächen (1)
- MRSA-colonised patients (1)
- MRSA-kolonisierten Patienten (1)
- MSIS (1)
- MSSA (1)
- Malaria (1)
- Map kinase (1)
- Markierungsgen (1)
- Mass critical care (1)
- Medicine (1)
- Medizinische Mikrobiologie (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningoencephalitis (1)
- Meningokokken-Infektion (1)
- Mesocestoides corti (1)
- Mesocestoides vogae (1)
- Metacestode (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Methicillin-resistenter S. aureus (1)
- Micafungin (1)
- Mikrodilution (1)
- Mikrodilutionstest (1)
- Mikroskopie (1)
- Mobile genetic element (1)
- Molekulargenetik (1)
- Moraxellaceae (1)
- Morphogenese (1)
- Morphologie (1)
- Morphology (1)
- Motilität (1)
- Mucin (1)
- Mucor (1)
- Mucorales (1)
- Multidrug-Resistenz (1)
- Multidrug-Resistenzen (1)
- Multilocus-Sequenz-Typisierung (1)
- Multilokus-Sequenztypisierung (1)
- Multiplex PCR (1)
- Multiresistenz (1)
- Multiresistenzen (1)
- Mutation FKS Hot Spot 1/ERG11 (1)
- Mwanza (1)
- Mycobacteria (1)
- Mycobacterium marinum (1)
- Mykobakterien (1)
- N-oleoyl serinol (1)
- NAD biosynthesis (1)
- NAD-Biosynthese (1)
- NAS (1)
- NCCLS (1)
- NMR-Tomographie (1)
- NR uptake (1)
- NR-Aufnahme (1)
- NadA (1)
- Nanos (1)
- NarE (1)
- Nasal Carriage (1)
- Neisseria meningitdis (1)
- Neisseria meningitis (1)
- Neisseria meníngitidis (1)
- Neisseriaceae (1)
- Neisserien (1)
- Neoblast (1)
- Nervous system (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuropeptide (1)
- Neutrallipide (1)
- Neutrophil Extracellular Traps (1)
- NmeDI (1)
- Non-coding RNA (1)
- Nosokomiale Infektion (1)
- Nursing homes (1)
- O Antigen-Ligase (1)
- O antigen-ligase (1)
- O-Antigen (1)
- O-acetylation (1)
- O-antigen (1)
- O103 (1)
- ONJ (1)
- OatC (1)
- Occludin (1)
- Oligonucleotide (1)
- Onchozerkose (1)
- One Health (1)
- Ontogenie (1)
- Opc (1)
- Optische Dichte (1)
- Osmolarität (1)
- Oxidativer Stress (1)
- P-glycoprotein (1)
- P-gp (1)
- P. aeruginosa (1)
- PHR (1)
- PHR/GAS (1)
- PHR3 (1)
- PMNs (1)
- Parasite (1)
- Parasitologie (1)
- Parasitäre Krankheit (1)
- Parvovirus (1)
- Pathogens (1)
- Penicillin G (1)
- Pentastomiasis (1)
- Periodontitis (1)
- Peroxidase (1)
- Peroxisom (1)
- Phasenvariation (1)
- PilX (1)
- Pilz (1)
- Pilzinfektionen (1)
- Plasmid (1)
- Plasminogen (1)
- Plasminogen-Aktivator (1)
- Plasminogen-Rezeptoren (1)
- Plathelminthes (1)
- Plattwürmer (1)
- Pneumococci (1)
- PnuC topology (1)
- PnuC-Topologie (1)
- Populationsbasierte Studie (1)
- Populationsstruktur (1)
- Predictive value of tests (1)
- Prevalence (1)
- ProQ (1)
- Proliferation (1)
- Proteintransport (1)
- Proteom analysis (1)
- Protoscolex (1)
- Prävention (1)
- Pulsfeldgelelektrophorese (1)
- Purpureocillium (1)
- Quantitative Echtzeit-Polymerase-Kettenreaktion (1)
- RAD (1)
- RIM10 (1)
- RNA (1)
- RNA chaperone Hfq (1)
- Real-time PCR (1)
- Receptor kinase (1)
- Regulatorischer T-Lymphozyt (1)
- Regulatory T-cell (1)
- RelA (1)
- Reportergen (1)
- Resistance mechanism C. auris (1)
- Resistenz (1)
- Resistenzbestimmung (1)
- Resistenztestung (1)
- Rettungsdienst (1)
- Rezeptorkinasen (1)
- Rhizomucor (1)
- Ribonucleasen (1)
- Ribosomale RNS <16S> (1)
- Rim101 (1)
- RpoS (1)
- S. aureus (1)
- SARS‐CoV‐2 (1)
- SCCmec (1)
- SFRP (1)
- ST 772 (1)
- ST1797 (1)
- ST88 (1)
- Saure Sphingomyelinase (1)
- Scavenger-Rezeptor (1)
- Scedosporium (1)
- Schistosoma mansoni (1)
- Schistosomiasis (1)
- Schlafkrankheit (1)
- Senioren (1)
- Sensibilität (1)
- Sequence analysis (1)
- Sequence motif analysis (1)
- Sequenzanalyse <Chemie> (1)
- Serogroup C (1)
- Serogruppe A (1)
- Serogruppe C (1)
- Serum (1)
- Shiga-Toxin (1)
- Shorttime transport (1)
- Sialyltransferase (1)
- Sierra Nevada (1)
- Signalsystem (1)
- Six3/6 Wnt (1)
- Skin (1)
- Small non-messenger RNS (1)
- Soor (1)
- Sphingolipidstoffwechsel (1)
- Sphingomyelinphosphodiesterase (1)
- Sphingosin (1)
- Spleißen (1)
- Split Decomposition Analyse (1)
- Split Decompostion Analysis (1)
- Stammbaum (1)
- Staphylococcus (1)
- Stem cells (1)
- Streptococcus agalactiae (1)
- Streptococcus suis (1)
- Stressreaktion (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Supercoiling (1)
- Surgery (1)
- Susceptibility Testing (1)
- Synthese (1)
- T Cells (1)
- T cells (1)
- TGF-BETA (1)
- TGF-beta (1)
- TGF-beta Signaling (1)
- TGFß (1)
- TGFß-Rezeptor (1)
- TGFß-receptor (1)
- TLR5 (1)
- TNF-alpha (1)
- TPS-System (1)
- Tansania (1)
- Telomerase (1)
- Thioredoxin (1)
- Tight junction (1)
- Toll like Rezeptor 4 (1)
- Toll like receptor 4 (1)
- ToxR DegS (1)
- Transcriptome (1)
- Transcriptome Analysis (1)
- Transforming Growth Factor beta (1)
- Transkriptional regulator (1)
- Transkriptionsprofil (1)
- Transkriptionsregulation (1)
- Transkriptionsregulator (1)
- Transkriptom (1)
- Transposon (1)
- Trematoden (1)
- Tropheryma whipplei (1)
- Tropomodulin (1)
- Tropomyosin (1)
- Trypanosoma brucei gambiense; Melarsoprol (1)
- Trypanosomiasis (1)
- Trägerrate (1)
- Tuberculosis (1)
- Two-Partner-secretion-system (1)
- Typ II-Rezeptor (1)
- Typ II-receptor (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- Urokinase (1)
- V. cholerae (1)
- Vaccination (1)
- Vaccinology (1)
- Valentine Leukocidin Genes (1)
- Vernachlässigte Tropenkrankheiten (1)
- Vesicles (1)
- Vibrio cholerae (1)
- Virulence (1)
- Virulenzfaktoren (1)
- WBC (1)
- Wachstumsrate (1)
- Wachstumsverhalten (1)
- Wasserstoffionenkonzentration (1)
- Whipple's disease (1)
- Wirkstoff (1)
- Wnt-Signalweg (1)
- Wnt-pathway (1)
- Wolbachia (1)
- Würmer (1)
- Würzburg / Institut für Hygiene und Mikrobiologie (1)
- Würzburger Universitäts-Kinderklinik (1)
- Xenopus oocytes (1)
- YeastOne (1)
- ZNS-Infektion (1)
- Zelldifferenzierung (1)
- Zellwand (1)
- Zestode (1)
- Zink (1)
- Zinkmangel (1)
- Zwei-Partner-Sekretions-Systeme (1)
- Zwei-Partner-Sekretionssystem (1)
- Zweidimensionale Gelelektrophorese (1)
- Zytoskelett (1)
- acid sphingomyelinase (1)
- acute watery diarrhea (1)
- adhesion (1)
- adhesion and invasion (1)
- admission screening (1)
- agar (1)
- agar diffusion test (1)
- agr (1)
- albicans (1)
- alloSCT patients (1)
- alpha5 beta1-Integrinrezeptor (1)
- alpha5 beta1-integrin receptor (1)
- alternative pig farming (1)
- alveoar echinococcosis (1)
- ambulance car (1)
- ampicillin (1)
- anaphylatoxin receptors (1)
- anaphylatoxins (1)
- angeborene Immunantwort (1)
- angeborene Immunität (1)
- anidulafungin (1)
- antero-posterior axis (1)
- antibiotic bone concentration (1)
- antibiotic prescription behavior (1)
- antibiotic susceptibility (1)
- antibiotic tolerance (1)
- antibiotic use (1)
- antibiotische Toleranz (1)
- antibodies (1)
- anticoagulants (1)
- antifungal susceptibility testing (1)
- antifungals (1)
- antigen testing (1)
- antigen-B (1)
- antigens (1)
- antimicrobial (1)
- antimicrobial peptides (1)
- antimicrobial responses (1)
- antimicrobials (1)
- antimikrobielle Peptide (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- anxiety (1)
- aquaporine (1)
- assay (1)
- attitude of health personnel (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- autochthonous infection (1)
- azole resistance (1)
- bactericidal activity (1)
- bednet (1)
- beta-Catenin (1)
- beta-lactam (1)
- beta-tubulin (1)
- beta‐d‐glucan (1)
- biological techniques (1)
- biomarker (1)
- biosynthesis (1)
- blood (1)
- blood fluke (1)
- blood stream infections (1)
- blood-cerebrospinal fluid barrier (1)
- bloodstream infection (1)
- body axis (1)
- brain barrier (1)
- brain endothelial cell (1)
- breakthrough (1)
- bronchoalveolar lavage fluid (1)
- cAMP (1)
- campylobacteriosis (1)
- candida albicans (1)
- capsule (1)
- capsule O-Acetylation (1)
- carbon dioxide (1)
- carbonic anhydrase (1)
- cardiovascular MRI (1)
- carriage rate (1)
- carriage study (1)
- caspase-3 (1)
- caspofungin (1)
- catalase (1)
- cell cycle (1)
- cell staining (1)
- cells (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- ceramide (1)
- ceramide analogs (1)
- cerebral persistance (1)
- cestodes (1)
- chaperone (1)
- chemical properties (1)
- chemotaxis (1)
- children (1)
- cholesterol (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- circulating (1)
- clonality (1)
- clone libraries (1)
- cnl-Meningokokken (1)
- coagulase-negative staphylococci (1)
- commercial kits (1)
- community settings (1)
- complement (1)
- complement system (1)
- complex (1)
- cord blood (1)
- core oligosaccharide (1)
- corticosteroids (1)
- cryptic (1)
- ctrA Gen (1)
- cutibacteria (1)
- cytokines (1)
- cytoskeleton (1)
- dRNA-seq (1)
- dendritic cell (1)
- dendritic cells (1)
- dendritiric cells (1)
- dendritische Zellen (1)
- depression (1)
- detection limits (1)
- development (1)
- differential age distribution (1)
- digital phenotyping (1)
- dimorhism (1)
- disease-associated (1)
- disinfection (1)
- dual function (1)
- dubliniensis (1)
- e. multilocularis (1)
- echinocandin (1)
- echinocandins (1)
- echinococcosis (1)
- echinococcus (1)
- ecological momentary assessment (1)
- ecology (1)
- efflux pumps (1)
- elucidation (1)
- endophthalmitis (1)
- endothelial cells (1)
- enzyme (1)
- epgenetics (1)
- epidermal growth factor (1)
- epithelial and endothelial cells (1)
- evolution (1)
- excretory-secretory (1)
- expert recommendation (1)
- extracellular (1)
- eye infection (1)
- fHbp (1)
- factor H (1)
- fatty acid resistence (1)
- feasibility study (1)
- fibronectin (1)
- field gel-electrophoreresis (1)
- filamentation (1)
- flat worms (1)
- flow cytometry (1)
- fluorescence microscopy (1)
- fungal antigens (1)
- fungal infection (1)
- fungal molecular diagnostics (1)
- fungi (1)
- fungicidal activity (1)
- galectin-2 (1)
- gangliosides and lipid rafts (1)
- gen (1)
- gene (1)
- general practice (1)
- general practitioner (1)
- generalized anxiety disorder (1)
- genetic loci (1)
- genetic variation (1)
- genetics (1)
- genome (1)
- genome comparison (1)
- genomic databases (1)
- genomic island (1)
- genomic libraries (1)
- genomics (1)
- germinative cell (1)
- germinative cells (1)
- gesunde Träger (1)
- glabrata (1)
- global regulators (1)
- globale Regulatoren (1)
- glucan synthase (1)
- glutamate dehydrogenase (1)
- glutathione (1)
- granulosus (1)
- group-B (1)
- healthy carriers (1)
- heart (1)
- heat (1)
- helminth (1)
- helminths (1)
- hematopoietic stem cell transplantation (1)
- hemihepatectomy (1)
- hemolysin related protein B (1)
- homeoboxgenes (1)
- hospital-acquired methicillin-resistant Staphylococcus aureus (1)
- host defense (1)
- host response (1)
- host-pathogen interactions (1)
- host–pathogen interaction (1)
- hoxgenes (1)
- human behaviour (1)
- hydatid disease (1)
- hydrogels (1)
- hyphae (1)
- identification (1)
- imaging (1)
- immune evasion (1)
- immune impairment (1)
- immune response (1)
- immunogenetics (1)
- immunology (1)
- immunomodulation (1)
- immunoprecipitation (1)
- immunotherapy (1)
- in vitro Kultivierung (1)
- in vitro cultivation (1)
- indigenous (1)
- induced pluripotent stem cells (1)
- infection prevention (1)
- infections (1)
- infectious diseases management (1)
- influenzae (1)
- innate immune evasions (1)
- innate immune response (1)
- innate immunity (1)
- insulin (1)
- interstage aspiration (1)
- intervention strategies (1)
- intracellular (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- intrazellulär (1)
- invasive aspergillosis (1)
- invasive disease (1)
- invasive meningococcal disease (1)
- invasive meningococcal diseases (1)
- invasive pulmonary aspergillosis (1)
- invasiveness (1)
- jaw bone (1)
- joint aspiration (1)
- joint infection (1)
- katalase (1)
- keratitis (1)
- killing (1)
- kinase (1)
- knowledge (1)
- laboratory techniques and procedures (1)
- large animal models (1)
- larvae (1)
- lebendvakzine (1)
- leptomeningeal cells (1)
- leucocyte count (1)
- lipopolysaccharide (1)
- lipopolysaccharide biosynthesis (1)
- live-vaccine (1)
- liver (1)
- liver resection (1)
- livestock-associated staphylococci (1)
- long noncoding RNA (1)
- longitudinal studies (1)
- mRNA (1)
- mammalian genomics (1)
- mannan (1)
- marker (1)
- matrix metallopeptidase-1 (1)
- maximum liklihood (1)
- mebendazole (1)
- meningeal blood-csf barrier (1)
- meningitidis (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- meningococcal vaccine (1)
- meningokokken-impfstoff (1)
- metabolism (1)
- metacestode vesicles (1)
- metamorphosis (1)
- methyltransferase homolog (1)
- micafungin (1)
- mice (1)
- microRNA (1)
- microarray (1)
- microbial surface component recognising adhesive matrix molecules (1)
- microbiological culture (1)
- microbiology techniques (1)
- microscopy (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- mitochondria (1)
- mitochondrial dynamics (1)
- mitochondrial morphology (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular characterization (1)
- molecular differentiation (1)
- molecular epidemiology (1)
- molecular identification (1)
- molekulare Differenzierung (1)
- molekulare Identifizierung (1)
- monoclonal antibodies (1)
- monoclonal antibody (1)
- monocytes (1)
- monoklonale Antikörper (1)
- motility (1)
- mouse model (1)
- mouse models (1)
- multifaceted approaches (1)
- multilocus sequence typing (1)
- multiple myeloma (1)
- mycobacterial infection (1)
- mycophenolic acid (1)
- myocyte (1)
- myriocin (1)
- natamycin (1)
- natural killer cell (1)
- natural transformation (1)
- neglected diseases (1)
- neglected groups (1)
- neglected tropical disease (1)
- nematodes (1)
- neoblast (1)
- neonatal morbidity (1)
- neutrallipids (1)
- neutrophil granulocytes (1)
- neutrophile Granulozyten (1)
- nhba (1)
- niche adaptation (1)
- nitrite respiration (1)
- nitrites (1)
- non-aureus staphylococci (1)
- nonautonomous (1)
- nosocomial transmission (1)
- nuclear magnetic resonance (1)
- ocular infection (1)
- one-health approach (1)
- opc (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- oral microbiome (1)
- organic farming (1)
- organoid (1)
- osmolarity (1)
- outer membrane proteine Opc (1)
- outer membrane vesicles (1)
- outpatient (1)
- pJS-A (1)
- pJS-B (1)
- panton-valentine leukocidin (1)
- paradoxical effect (1)
- paradoxical growth (1)
- parasitic diseases (1)
- pathogene Pilze (1)
- pathogenicity (1)
- pathometabolism (1)
- pediatric (1)
- pediatrician (1)
- penA (1)
- penicillin resistance (1)
- periprosthetic joint infection (1)
- peroxisome (1)
- phylogeny (1)
- phylotypes (1)
- phylotypic (1)
- pig (1)
- pig farming methods (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- planarian (1)
- plasmid (1)
- plasminogen receptor (1)
- plexus epithelial-cells (1)
- pls (1)
- pluripotency (1)
- pnuC transporter (1)
- pnuC-Transporter (1)
- polymorphonuclear neutrophils (1)
- population biology (1)
- population genetics (1)
- post-operative antibiotic treatment (1)
- prevention (1)
- primary care (1)
- primary cells (1)
- probe-based real-time PCR (1)
- protein kinases (1)
- proteins (1)
- proteomic analysis (1)
- protoemanalysis (1)
- public health (1)
- pulsed field gel electrophoresis (1)
- qPCR (1)
- quality of life (1)
- real-time PCR (1)
- recombinant proteins (1)
- regulator (1)
- regulatory T cells (1)
- relA (1)
- reporter gene (1)
- rescue service (1)
- research infrastructure (1)
- resistance (1)
- retrotransposition (1)
- revision arthroplasty (1)
- rezeptorkinases (1)
- schistoma mansoni (1)
- sensitivity (1)
- sensitivity and specificity (1)
- septic (1)
- sequence (1)
- sequence analysis (1)
- sequence assembly tools (1)
- serogroup A (1)
- serogroup B (1)
- serogroup-Y (1)
- serology (1)
- seroprevalence (1)
- serum (1)
- shiga toxin (1)
- shock (1)
- siaD (1)
- sialyltransferase (1)
- signaling (1)
- single-molecule tracking (1)
- sirolimus (1)
- sleeping sickness (1)
- small RNA (1)
- small interfering RNAs (1)
- spa (1)
- spa typing (1)
- splicing (1)
- sporidia (1)
- state-based model (1)
- stem cell transplantation (1)
- strain MC58 (1)
- strain specificity (1)
- stress response (1)
- stringent response (1)
- structural determination (1)
- super-resolution microscopy (1)
- surgical intra-abdominal infections (1)
- survey (1)
- synthesis (1)
- systems biology (1)
- taxonomy (1)
- tazobactam (1)
- testing strategy (1)
- therapy (1)
- throat (1)
- tight junctions (1)
- topic ofloxacin (1)
- transcription factors (1)
- transcriptional regulation (1)
- transcriptome data analysis (1)
- translational research (1)
- transplantation (1)
- transposable elements (1)
- tropomodulin (1)
- tropomyosin (1)
- trypanosoma (1)
- tsetse-flies (1)
- two-dimensional gelelectrophoresis (1)
- two-partner secretion system (1)
- two-partner-secretion-system (1)
- ultrahigh-field MRI (1)
- uncultivated bacteria (1)
- under five children (1)
- upper extremity (1)
- utilization (1)
- vaccine development (1)
- vaccines (1)
- vesicles (1)
- viral load (1)
- virulenceregulatory evolution (1)
- vitrectomy (1)
- water microbiology (1)
- white blood cell count (1)
- whole blood ex vivo model (1)
- whole genome sequence (1)
- whole-blood infection assay (1)
- whole-blood model (1)
- zerebrale Persistenz (1)
- zinc cluster transcription factor (1)
- zinc limitation (1)
- äußere Membranvesikel (1)
- γ-glutamyl cycle (1)
Institute
- Institut für Hygiene und Mikrobiologie (226) (remove)
Sonstige beteiligte Institutionen
- Broad Institute, USA (1)
- Department Pharmazie - Zentrum für Pharmaforschung, Ludwig-Maximilians-Universität München (1)
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Instituto de Higiene, Universidad de la República, Montevideo, Uruguay (1)
- Instituto de Hygiene Montevideo, Uruguay (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (1)
- Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie Hans-Knöll-Institut (1)
EU-Project number / Contract (GA) number
- 2016 FGR 0053 (1)
- 278864 (1)
- 847507 (1)
Fusarium (F.)-Infektionen des Auges zeigen oft einen schwerwiegenden Verlauf und sind am häufigsten mit Spezies des Fusarium solani species complex assoziiert. Dabei sind das Tragen von weichen Kontaktlinsen sowie Traumata die wichtigsten prädisponierenden Faktoren. Vorangegangene Untersuchungen des Nationalen Referenzzentrums für invasive Pilzinfektionen hatten ergeben, dass Infektionen durch F. petroliphilum mit der Nutzung von Kontaktlinsen, Infektionen durch F. falciforme jedoch überwiegend traumaassoziiert uns vor allem aus tropischen und subtropischen Ländern bekannt sind.
Das Ziel dieser Arbeit war es daher zu untersuchen, ob F. falcifomre und F. petroliphilum physiologische Merkmale aufweisen, die für die Unterschiede in den Risikofaktoren für Keratitiden durch die beiden Arten verantwortlich sein könnten.
Die Zahl invasiver Pilzinfektionen ausgelöst durch C. glabrata steigt zunehmend und auch die Ausbildung multipler Resistenzen wird immer häufiger registriert. In dieser Arbeit wurden zwei klinische MDR-C. glabrata-Stämme systematisch analysiert, um den Ursprung der Mehrfachresistenz zu finden. Aufgefallen waren jene Isolate in vorhergehenden Untersuchungen von Aldejohann et. al., die 176 Stämme, die dem Referenzzentrum NRZ-Myk zugesandt wurden, auf ihr Resistenzverhalten gegen Echinocandine analysierten und auf FKS-Mutationen untersuchten. Die Isolate CG22 und CG56 zeigten ein Resistenzverhalten gegen Anidulafungin ohne eine FKS-Mutation aufzuweisen. In Mehrfachtestungen wurde das einheitliche Verhalten von CG56 in zehn Einzelkolonien verifiziert, um Mischkulturen oder heterogenes Verhalten innerhalb des Isolates ausschließen zu können. Nach Analyse der gesamten Genomsequenz von CG56 zeigte sich eine Mutation kurz vor der HS-Region von FKS2, die eine Erklärung für das Resistenzverhalten zu liefern scheint. Neben der Mutation in FKS2 wurde ebenfalls eine Mutation in FKS1 und in ERG3 bestätigt. Die Mutation in ERG3 führt zu einer Verschiebung im Sterolsynthesepathway und zu einer Neuverteilung der Zellmembranbestandteile. Das klinische Isolat CG22 fällt mit Resistenzen gegen Azole, Echinocandine und Amphotericin B auf und zeigte ebenfalls eine Mutationen in ERG3. Zusätzlich dazu ergab sich eine Loss-of- Function-Mutation in ERG4 und damit verbunden einen massiv reduzierten Ergosterolgehalt der Zellmembran. Die seltene Kombination aus ERG3 und ERG4 Mutation scheint die Erklärung für die außergewöhnliche Amphotericin B-Resistenz von CG22 zu liefern und wird hier als erstmals bei einem C. glabrata Isolat beschrieben. Dieser besondere Stamm, der sogar als panresistent bezeichnet werden kann, sollte Bestandteil weiterer Forschung werden. Der Sterolsynthesepathway dient als Angriffspunkt vieler Antimykotika und kann durch seine vielen Intermediate und abweichenden Abläufen zu unterschiedlichen Stoffwechselendprodukten führen. Der Ergosterolgehalt der Zellmembran eines C. glabrata-Stammes kann weitere Rückschlüsse auf die Empfindlichkeit des Isolates geben und somit die Chancen des Therapieerfolges der Antimykotikagabe besser vorhersagen und könnte somit einen vielversprechenden Beitrag zur Behandlung lebensbedrohlicher Candidosen leisten.
Die Inzidenz invasiver H. influenzae-Infektionen in Deutschland steigt seit Jahren an. Die akkurate Identifizierung und Resistenztestung dieses Erregers sind von großer klinischer und epidemiologischer Bedeutung. Daher wurden im Rahmen der vorliegenden Promotionsarbeit umfangreiche Untersuchungen zur Diagnostik und zur Epidemiologie von Antibiotikaresistenzen bei H. influenzae durchgeführt.
Es konnte gezeigt werden, dass die in der Routinediagnostik mittlerweile weit verbreitete MALDI-TOF-MS-Diagnostik durch das VITEK MS IVD nur eingeschränkt zur sicheren Unterscheidung von H. influenzae und H. haemolyticus einsetzbar ist. H. influenzae-Isolate erkannte das System mit einer Genauigkeit von 100 %. Bei H. haemolyticus-Isolaten wurden dagegen 42 % der untersuchten Stämme fälschlicherweise als H. influenzae erkannt. Dieser Fragestellung wurde mit der bisher umfangreichsten molekularbiologisch charakterisierten Studienpopulation beider Bakterienspezies nachgegangen.
Die kalkulierte antibiotische Therapie einer Sepsis oder Meningitis erfolgt häufig mit Carbapenemen, die leitliniengerechte Therapie invasiver H. influenzae-Infektionen mit Drittgenerations-Cephalosporinen. Imipenem und Cefotaxim gehören zu den Hauptvertretern dieser Gruppen. Bezüglich der Antibiotikaresistenztestung wurde erstmalig für H. influenzae herausgefunden, dass die routinemäßig verwendete Gradientenagardiffusion (GAD) bei der Testung von Cefotaxim im Vergleich zum Goldstandard Bouillon-Mikrodilution gleichwertig und bei Imipenem sogar sensitiver in der Detektion von Heteroresistenzen ist.
Die Epidemiologie dieser Resistenzen wurde in dieser Arbeit erstmalig für Deutschland systematisch erfasst, indem alle verfügbaren invasiven Isolate gemeldeter H. influenzae-Infektionen der Jahre 2016 (Imipenem) beziehungsweise 2016-2019 (Cefotaxim) untersucht wurden. Es wurde eine hohe Prävalenz einer Imipenem-Resistenz von 13,5 % festgestellt. Die Prävalenz einer Cefotaxim-Resistenz lag bei 0,9 %.
Zur molekularen Typisierung wurde bei den Imipenem-resistenten Isolaten eine Multilocus-Sequenztypisierung, bei den Cefotaxim-resistenten Stämmen eine Sequenzierung des vollständigen Genoms durchgeführt. Hierbei wurde eine hohe genetische Diversität der Stämme festgestellt, was die Schlussfolgerung zulässt, dass resistente Mutanten sporadisch entstehen. Die Untersuchung möglicher spatio-temporaler Cluster führte zum Nachweis einer sehr selten vorkommenden Übertragung eines Imipenem-resistenten Stamms. Durch die Sequenzierung von Resistenzgenen wurde die Epidemiologie und Relevanz bekannter Aminosäuresubstitutionen beleuchtet. Unter anderem wurde für die PBP3-Substitutionen L389F und Y557H eine hochsignifikante Korrelation mit dem Auftreten von Cefotaxim-Resistenzen nachgewiesen. Die gewonnenen Genomdaten bieten die Grundlage für die Forschung an weiteren Antibiotikaresistenzdeterminanten von H. influenzae.
Echinococcosis is an important zoonosis. The causative agent of Alveolar Echinococcosis (AE) is Echinococcus multilocularis. The treatment of human AE is limited to surgery and chemotherapy with albendazole (ABZ). However, ABZ works only parasitostatically and it needs to be taken for long periods, although it causes adverse side effects. Thus, development of new, parasiticidal drug with selective toxicity is required. Because undifferentiated stem cells of E. multilocularis play key role in its longevity and regenerative capacity, targeting stem cells is especially important.
In vitro screening of protein kinases inhibitors demonstrated that human PIM kinases inhibitors have detrimental effects on E. multilocularis. Through yeast two hybrid assay, the interaction of parasite PIM kinase (EmPIM) and its CDC25 (EmCDC25) was indicated. Through in situ hybridization, expression of EmPIM in the stem cells was observed. Therefore, EmPim is likely to be a positive regulator of cell cycle progression, the same as human Pim1. In addition, 20 compounds against EmPIM were selected through in silico screening and synthesized. One of them has a detrimental effect on E.multilocularis comparable to human pan-PIM inhibitors, but has much weaker toxicity on human cell lines.
Furthermore, triclabendazole (TCBZ) and its metabolite TCBZSX, which are approved for another flatworm disease, Fascioliasis were tried on E. multilocularis. With two stem cell markers, damage to stem cells by TCBZSX was shown. In addition, primary cells from treated vesicles never regenerated and the damage to stem cells proved to be irreversible.
Our in silico screening method used in EmPIM research has potential to identify compounds which overcome the side effect problem in ABZ-based chemotherapy. On the other hand, it is expected that my research of TCBZ can lead to development of a practical parasiticidal chemotherapy by combining TCBZ, which damages stem cells, and ABZ, which damages differentiated cells.
High seroprevalence of SARS-CoV-2 in Mwanza, northwestern Tanzania: a population-based survey
(2022)
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus antibodies in the communities of three different districts in the Mwanza region, Tanzania. A household cross-sectional survey was conducted in September 2021 using the modified African Centre for Disease and Prevention (ACDC) survey protocol. A blood sample was obtained from one member of each of the selected households who consented to take part in the survey. Immunochromatographic rapid test kits were used to detect IgM and IgG SARS-CoV-2 antibodies, followed by descriptive data analysis. Overall, 805 participants were enrolled in the study with a median age of 35 (interquartile range (IQR):27–47) years. The overall SARS-CoV-2 seropositivity was 50.4% (95%CI: 46.9–53.8%). The IgG and IgM seropositivity of the SARS-CoV-2 antibodies was 49.3% and 7.2%, respectively, with 6.1% being both IgG and IgM seropositive. A history of runny nose (aOR: 1.84, 95%CI: 1.03–3.5, p = 0.036), loss of taste (aOR: 1.84, 95%CI: 1.12–4.48, p = 0.023), and living in Ukerewe (aOR: 3.55, 95%CI: 1.68–7.47, p = 0.001) and Magu (aOR: 2.89, 95%CI: 1.34–6.25, p= 0.007) were all independently associated with SARS-CoV-2 IgM seropositivity. Out of the studied factors, living in the Ukerewe district was independently associated with IgG seropositivity (aOR 1.29, CI 1.08–1.54, p = 0.004). Twenty months after the first case of COVID-19 in Tanzania, about half of the studied population in Mwanza was seropositive for SARS-CoV-2.
Candida auris was first described as a yeast pathogen in 2009. Since then, the species has emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi-drug resistance and is readily transmitted in hospital settings. While most detections so far are from colonised patients, C. auris does cause superficial and life-threatening invasive infections. During management of the first documented C. auris transmission in a German hospital, experts from the National Reference Centers for Invasive Fungal Infections (NRZMyk) and the National Reference Center for Surveillance of Nosocomial Infections screened available literature and integrated available knowledge on infection prevention and C. auris epidemiology and biology to enable optimal containment. Relevant recommendations developed during this process are summarised in this guidance document, intended to assist in management of C. auris transmission and potential outbreak situations. Rapid and effective measures to contain C. auris spread require a multi-disciplinary approach that includes clinical specialists of the affected unit, nursing staff, hospital hygiene, diagnostic microbiology, cleaning staff, hospital management and experts in diagnostic mycology / fungal infections. Action should be initiated in a step-wise process and relevant interventions differ between management of singular C. auris colonised / infected patients and detection of potential C. auris transmission or nosocomial outbreaks.
Diagnosis and therapy of Mycobacterium marinum: a single-center 21-year retrospective analysis
(2022)
Background and Objectives
In Europe, infections with Mycobacterium (M.) marinum are rare. We conducted a retrospective single-center study to assess the clinical spectrum of M. marinum infection and its diagnosis, treatment and outcome under real-world conditions.
Patients and Methods
Eighteen patients presenting with M. marinum infections between 1998 and 2018 were identified in the data warehouse of the University Hospital Würzburg and considered for detailed analysis.
Results
Twelve patients reported aquatic exposure. In 16/18 cases the upper extremities were affected. No invasive infections were detected. Mean time to diagnosis was 15 weeks. Histology revealed granulomatous inflammation in 14 patients while mycobacterial cultures were positive for M. marinum in 16 cases. Most patients received antibiotic monotherapy (14/18) while combination therapy was administered in four cases. Treatment (with a median duration of 10 weeks) was successful in 13 patients. Five patients were lost to follow-up.
Conclusions
Our retrospective analysis of M. marinum infections at a German tertiary referral center revealed a considerable diagnostic delay and the relevance of microbiological culture, PCR and histology for diagnosis. Monotherapy with clarithromycin (rather than doxycycline) appeared as a reasonable treatment option while immunosuppressed or -compromised patients and those with extended disease received combination therapy.
Purpose
Fungal biomarkers support early diagnosis of invasive fungal infections. In this study, we evaluated the impact of a recent update to the manufacturer‐recommended cut‐off for beta‐1,3‐D‐glucan (BDG) testing (Fujifilm Wako BDG assay) on sensitivity and specificity for the detection of candidemia. Additionally, we compared the performance with tests for Candida antigen (Ag by Serion ELISA antigen Candida, Virion\Serion) and anti‐mannan antibodies (Ab by Hemkit Candida IHA, Ravo Diagnostika).
Methods
Sera of 82 patients with candidemia, which were sampled with a maximum distance of ±14 days from the date of sampling of the corresponding positive blood cultures, were retrospectively analysed for BDG, Ag and Ab. Results of BDG testing were compared with results from sera of 129 patients with candidemia from a different hospital.
Results
Sensitivity of BDG testing (47%) was higher than for Ag (17%) or Ab (20%). By combining Ag and Ab testing, sensitivity was raised to 32%. Lowering the cut‐off of BDG from 11 pg/ml to the newly recommended cut‐off of 7 pg/ml resulted in a significant increase in sensitivity (47% vs 58%, p = .01 and 63% vs 71% p < .01). At both centres, the increase was significant in NAC but not in C. albicans candidemia. No significant effects on specificity were observed.
Conclusion
BDG testing outperformed Ag and Ab testing and its combination. Lowering the BDG cut‐off had no significant impact on specificity. The increase in sensitivity can be mainly attributed to a gain in sensitivity for non‐albicans Candida species bloodstream infections.
Bei dem 2009 erstbeschriebenen Hefepilz C. auris handelt es sich um einen Keim, welcher aufgrund von nosokomialen Ausbrüchen und hohen Antimykotikaresistenzen Aufmerksamkeit erregte. Ziel dieser Arbeit war es in Deutschland gesammelte Isolate bezüglich vorhandener Resistenzen und Mutationen in Resistenzregionen zu testen und das epidemiologische Geschehen hierzulande mit dem globalen Auftreten des Keims zu vergleichen. Bezüglich der durchgeführten Resistenztestungen wiesen die CLSI-konformen Testarten (YO-Platten und E-Test-Verfahren) meist vergleichbare Ergebnisse auf. Für das EUCAST-konforme Mikrodilutionstestverfahren kann aufgrund eines stark ausgeprägten paradoxen Wachstumseffekts nur Anidulafungin, nicht jedoch Caspofungin, zur Testung empfohlen werden. Insgesamt erwiesen sich 25 % der Isolate als Caspofungin-resistent. Zwei Isolate zeigten eine Resistenz gegenüber allen getesteten Echinocandinen (16,7 %). Die höchsten Resistenzraten wurden gegenüber Fluconazol (92 %) beobachtet. Zwei der Isolate zeigten sich gegenüber Voriconazol resistent (16,7 %). Für Amphotericin B konnte eine Resistenzrate von 33,3 % festgestellt werden. Für die Wirkstoffe Posaconazol und Itraconazol erwiesen sich alle untersuchten Isolate als sensitiv. Dies konnte auch mit Ausnahme eines Isolates für 5-Flucytosin beobachtet werden. Die durch eine Sanger-Sequenzierung erhaltenen Sequenzen der Gene FKS1 und ERG11 wurden auf Mutationen untersucht, welche zu Aminosäuresubstitutionen im Gesamtprotein führten. Hierbei ergaben sich für zwei Isolate (16,7 %) Mutationen im FKS1-Hot Spot 1 (Typ S639F und S639Y). Beide Isolate zeigten sich in den AFST Echinocandin-resistent. Bei allen untersuchten Isolaten lagen Mutationen im ERG11 Gen vor. So fand sich in 8 Fällen eine Mutation des Typen Y132F (66,7 %), in 3 Fällen der Typ K143R (25 %) und in einem Fall der Typ F126L (8,3 %). Im Rahmen eines anderen Projekts wurde mit den hier gewonnenen PCR-Produkten ein WGS durchgeführt, um die Isolate durch SNPs-Vergleich mit Referenzstämmen phylogenetischen Clades zuzuordnen. Dabei konnten 91,7 % der Isolate dem südasiatischen Clade I und ein Isolat dem südafrikanischen Clade III zugeordnet werden. Aufgrund der geringen epidemiologischen Fallzahlen in Deutschland scheint gegenwärtig keine Bedrohung von C. auris auszugehen. Berichte aus anderen Ländern konnten allerdings eine rasche, ausbruchartige Zunahme von C. auris Fällen nachweisen. So kann nur angeraten werden das infektiologische Geschehen in Deutschland weiterhin zu beobachten.